BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Larramona G, Lucendo AJ, González-Castillo S, Tenias JM. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol 2011; 3(12): 300-307 [PMID: 22216370 DOI: 10.4254/wjh.v3.i12.300] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Baeg MK, Yoon SK, Ko S, Han K, Choi HJ, Bae SH, Choi JY, Choi M. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys. Hepatol Int 2016;10:470-7. [DOI: 10.1007/s12072-015-9672-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Çetinkaya A, Özen H, Yüce A, Saltık-temizel İN, Demir H, Gürakan F. Bone mineralization in children with Wilson’s disease. Indian J Gastroenterol 2014;33:427-31. [DOI: 10.1007/s12664-014-0468-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Tariq S, Tariq S, Hussain S, Baig M. Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker. Pak J Med Sci 2020;36:1325-9. [PMID: 32968402 DOI: 10.12669/pjms.36.6.2678] [Reference Citation Analysis]
4 Argirion I, Pfeiffer RM, Lam TK, O'Brien TR, Yu K, McGlynn KA, Petrick JL, Pinto L, Chen CJ, Lee MH, Hildesheim A, Yang HI, Koshiol J. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B. Sci Rep 2021;11:21194. [PMID: 34782638 DOI: 10.1038/s41598-021-00455-8] [Reference Citation Analysis]
5 Kawazoe Y, Miyauchi M, Nagasaki A, Furusho H, Yanagisawa S, Chanbora C, Inubushi T, Hyogo H, Nakamoto T, Suzuki K, Moriwaki S, Tazuma S, Niida S, Takata T. Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody. PLoS One 2015;10:e0139620. [PMID: 26418133 DOI: 10.1371/journal.pone.0139620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xu X, Wang R, Wu R, Yan W, Shi T, Jiang Q, Shi D. Trehalose reduces bone loss in experimental biliary cirrhosis rats via ERK phosphorylation regulation by enhancing autophagosome formation. FASEB j 2020;34:8402-15. [DOI: 10.1096/fj.201902528rrr] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
7 Zhu M, Xu LM. Relationship between vitamin D and chronic liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(18): 1714-1719 [DOI: 10.11569/wcjd.v21.i18.1714] [Reference Citation Analysis]
8 López-Larramona G, Lucendo AJ, Tenías JM. Association between nutritional screening via the Controlling Nutritional Status index and bone mineral density in chronic liver disease of various etiologies. Hepatol Res. 2014; Jul 25. [Epub ahead of print]. [PMID: 25059921 DOI: 10.1111/hepr.12395] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jadzic J, Cvetkovic D, Milovanovic P, Tomanovic N, Zivkovic V, Nikolic S, Djuric M, Djonic D. The micro-structural analysis of lumbar vertebrae in alcoholic liver cirrhosis. Osteoporos Int 2020;31:2209-17. [DOI: 10.1007/s00198-020-05509-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Grant C. A vitamin D protocol post‐liver transplantation. Journal of the American Association of Nurse Practitioners 2017;29:658-66. [DOI: 10.1002/2327-6924.12503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Santos LA, Romeiro FG. Diagnosis and Management of Cirrhosis-Related Osteoporosis. Biomed Res Int. 2016;2016:1423462. [PMID: 27840821 DOI: 10.1155/2016/1423462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
12 Jadzic J, Milovanovic P, Cvetkovic D, Ivovic M, Tomanovic N, Bracanovic M, Zivkovic V, Nikolic S, Djuric M, Djonic D. Mechano-structural alteration in proximal femora of individuals with alcoholic liver disease: Implications for increased bone fragility. Bone 2021;150:116020. [PMID: 34044170 DOI: 10.1016/j.bone.2021.116020] [Reference Citation Analysis]
13 Wang P, Gao XS, Zhang YN, Duan XF. Progress in research of non-cirrhotic chronic viral hepatitis with osteoporosis. Shijie Huaren Xiaohua Zazhi 2022; 30(11): 491-497 [DOI: 10.11569/wcjd.v30.i11.491] [Reference Citation Analysis]
14 Kizilgul M, Ozcelik O, Delibasi T. Bone health and vitamin D status in alcoholic liver disease. Indian J Gastroenterol 2016;35:253-9. [PMID: 27246833 DOI: 10.1007/s12664-016-0652-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Chapin CA, Bass LM. Cirrhosis and Portal Hypertension in the Pediatric Population. Clin Liver Dis. 2018;22:735-752. [PMID: 30266160 DOI: 10.1016/j.cld.2018.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
16 Ng NBH, Karthik SV, Lee YS, Aw MM. Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor-23. J Paediatr Child Health 2022. [PMID: 35486438 DOI: 10.1111/jpc.16001] [Reference Citation Analysis]
17 Karoli Y, Karoli R, Fatima J, Manhar M. Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease. J Clin Diagn Res 2016;10:OC31-4. [PMID: 27656483 DOI: 10.7860/JCDR/2016/21539.8367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Kim SH, Yang TU, Choi BK, Yoo HJ, Seo JA, Choi KM, Kim NH, Kim SG, Baik SH, Choi DS, Choi HY. A Case of Multiple Osteoporotic Compression Fractures in Young Man with Budd-Chiari Syndrome. Endocrinol Metab 2012;27:334. [DOI: 10.3803/enm.2012.27.4.334] [Reference Citation Analysis]
19 Womack JA, Goulet JL, Gibert C, Brandt CA, Skanderson M, Gulanski B, Rimland D, Rodriguez-Barradas MC, Tate J, Yin MT, Justice AC; Veterans Aging Cohort Study Project Team. Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis 2013;56:1498-504. [PMID: 23378285 DOI: 10.1093/cid/cit056] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 8.3] [Reference Citation Analysis]
20 Selmi C, Generali E, Gershwin ME. Rheumatic Manifestations in Autoimmune Liver Disease. Rheumatic Disease Clinics of North America 2018;44:65-87. [DOI: 10.1016/j.rdc.2017.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Fernandes B, Dias E, Mascarenhas-Saraiva M, Bernardes M, Costa L, Cardoso H, Macedo G. Rheumatologic manifestations of hepatic diseases. Ann Gastroenterol 2019;32:352-60. [PMID: 31263357 DOI: 10.20524/aog.2019.0386] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Zarrinpar A, Busuttil RW. Immunomodulating options for liver transplant patients. Expert Rev Clin Immunol 2012;8:565-78; quiz 578. [PMID: 22992151 DOI: 10.1586/eci.12.47] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
23 Patel N, Muñoz SJ. Bone disease in cirrhosis. Clin Liver Dis (Hoboken) 2015;6:96-9. [PMID: 31040999 DOI: 10.1002/cld.498] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
24 Jadzic J, Cvetkovic D, Tomanovic N, Zivkovic V, Nikolic S, Milovanovic P, Djuric M, Djonic D. The severity of hepatic disorder is related to vertebral microstructure deterioration in cadaveric donors with liver cirrhosis. Microsc Res Tech 2021;84:840-9. [PMID: 33170963 DOI: 10.1002/jemt.23642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Bajoria R, Rekhi E, Almusawy M, Chatterjee R. Hepatic Hemosiderosis Contributes to Abnormal Vitamin D-PTH Axis in Thalassemia Major. Journal of Pediatric Hematology/Oncology 2019;41:e83-9. [DOI: 10.1097/mph.0000000000001261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Liu Z, Han T, Werner H, Rosen CJ, Schaffler MB, Yakar S. Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass. J Bone Miner Res 2018;33:123-36. [PMID: 28902430 DOI: 10.1002/jbmr.3290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
27 Goldner D, Vittorio J, Barrios DM, Mcguire J, Brodlie S, Brown J, Lobritto S, Martinez M. Bone Fractures in Children With Cholestatic Liver Disease May Mimic Those Seen in Child Abuse. Pediatric Emergency Care 2019;Publish Ahead of Print. [DOI: 10.1097/pec.0000000000001740] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Nandivada P, Potemkin AK, Carlson SJ, Chang MI, Cowan E, O'Loughlin AA, Gura KM, Puder M. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease. JPEN J Parenter Enteral Nutr 2015;39:973-6. [PMID: 25106918 DOI: 10.1177/0148607114545995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
29 Sinclair M, Grossmann M, Hoermann R, Angus PW, Gow PJ. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial. J Hepatol. 2016;65:906-913. [PMID: 27312945 DOI: 10.1016/j.jhep.2016.06.007] [Cited by in Crossref: 113] [Cited by in F6Publishing: 97] [Article Influence: 18.8] [Reference Citation Analysis]
30 Gaudio A, Pennisi P, Muratore F, Bertino G, Ardiri A, Pulvirenti I, Tringali G, Fiore CE. Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: A peripheral quantitative computed tomography (pQCT) study. European Journal of Internal Medicine 2012;23:656-60. [DOI: 10.1016/j.ejim.2012.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bell JE, Amin R, Labaran LA, Sequeira SB, Rao SS, Werner BC. Impact of Compensated Cirrhosis Etiology on Postoperative Outcomes Following Total Knee Arthroplasty. J Arthroplasty 2021;36:148-153.e1. [PMID: 32739079 DOI: 10.1016/j.arth.2020.07.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Lu K, Shi TS, Shen SY, Shi Y, Gao HL, Wu J, Lu X, Gao X, Ju HX, Wang W, Cao Y, Chen D, Li CJ, Xue B, Jiang Q. Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression. Cell Metab 2022;34:441-457.e7. [PMID: 35235775 DOI: 10.1016/j.cmet.2022.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Handzlik-Orlik G, Holecki M, Wilczyński K, Duława J. Osteoporosis in liver disease: pathogenesis and management. Ther Adv Endocrinol Metab 2016;7:128-35. [PMID: 27293541 DOI: 10.1177/2042018816641351] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
34 Woo GA, O'Brien C. Long-term management of alcoholic liver disease. Clin Liver Dis 2012;16:763-81. [PMID: 23101981 DOI: 10.1016/j.cld.2012.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
35 Fisher L, Srikusalanukul W, Fisher A, Smith P. Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes. Int J Med Sci 2015;12:100-15. [PMID: 25589886 DOI: 10.7150/ijms.10696] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
36 Pietschmann N, Rijntjes E, Hoeg A, Stoedter M, Schweizer U, Seemann P, Schomburg L. Selenoprotein P is the essential selenium transporter for bones. Metallomics 2014;6:1043-9. [PMID: 24626785 DOI: 10.1039/c4mt00003j] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
37 Hidalgo DF, Boonpheng B, Sikandar S, Nasr L, Hidalgo J. Chronic Liver Disease and the Risk of Osteoporotic Fractures: A Meta-Analysis. Cureus 2020;12:e10483. [PMID: 33083184 DOI: 10.7759/cureus.10483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ehnert S, Aspera-Werz RH, Ruoß M, Dooley S, Hengstler JG, Nadalin S, Relja B, Badke A, Nussler AK. Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. Int J Mol Sci 2019;20:E2555. [PMID: 31137669 DOI: 10.3390/ijms20102555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
39 Eltayeb AA, Abdou MAA, Abdel-aal AM, Othman MH. Vitamin D status and viral response to therapy in hepatitis C infected children. World J Gastroenterol 2015; 21(4): 1284-1291 [PMID: 25632203 DOI: 10.3748/wjg.v21.i4.1284] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
40 Veraldi S, Pietrobattista A, Liccardo D, Basso MS, Mosca A, Alterio T, Cardile S, Benedetti S, Della Corte C, Candusso M. Fat soluble vitamins deficiency in pediatric chronic liver disease: The impact of liver transplantation. Digestive and Liver Disease 2020;52:308-13. [DOI: 10.1016/j.dld.2019.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Knudsen AW, Krag A, Nordgaard-Lassen I, Frandsen E, Tofteng F, Mortensen C, Becker U. Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites. Scand J Gastroenterol 2016;51:601-9. [PMID: 26673350 DOI: 10.3109/00365521.2015.1124282] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
42 Arora A, Rajesh S, Bansal K, Sureka B, Patidar Y, Thapar S, Mukund A. Cirrhosis-related musculoskeletal disease: radiological review. Br J Radiol 2016;89:20150450. [PMID: 27356209 DOI: 10.1259/bjr.20150450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Jadžić J, Đonić D. Compromised bone strength in patients with alcoholic liver cirrhosis. Medicinski podmladak 2020;71:27-34. [DOI: 10.5937/mp71-27443] [Reference Citation Analysis]
44 Pereira FA, Mattar R, Facincani I, Defino HL, Ramalho LN, Jorgetti V, Volpon JB, de Paula FJ. Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. Braz J Med Biol Res 2012;45:1255-61. [PMID: 22983176 DOI: 10.1590/s0100-879x2012007500143] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Silva MC, Silva TE, Aires de Alentar ML, Coelho MSPH, Wildner LM, Bazzo ML, González-chica DA, Dantas-corrêa EB, Narciso-schiavon JL, Schiavon LDL. Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis. Annals of Hepatology 2015;14:99-107. [DOI: 10.1016/s1665-2681(19)30806-3] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Min C, Bang WJ, Kim M, Oh DJ, Choi HG. The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort. Arch Osteoporos 2019;14:34. [PMID: 30852676 DOI: 10.1007/s11657-019-0590-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Hochrath K, Ehnert S, Ackert-Bicknell CL, Lau Y, Schmid A, Krawczyk M, Hengstler JG, Dunn J, Hiththetiya K, Rathkolb B, Micklich K, Hans W, Fuchs H, Gailus-Durner V, Wolf E, de Angelis MH, Dooley S, Paigen B, Wildemann B, Lammert F, Nüssler AK. Modeling hepatic osteodystrophy in Abcb4 deficient mice. Bone 2013;55:501-11. [PMID: 23545228 DOI: 10.1016/j.bone.2013.03.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]